![GMP-gerechte Herstellung von Gen- und Zelltherapeutika in einem Speziallabor der Charité © Charité | Arne Sattler / GMP-compliant manufacturing of gene and cell therapies in a special lab at Charité © Charité | Arne Sattler GMP-gerechte Herstellung von Gen- und Zelltherapeutika in einem Speziallabor der Charité © Charité | Arne Sattler / GMP-compliant manufacturing of gene and cell therapies in a special lab at Charité © Charité | Arne Sattler](/uploads/images/_scale/zelltherapien_gmp_becat__id_5074____charit_arne_sattler_169_626x352.jpg)
-
- Science
EU-funded JOIN4ATMP project aims to overcome regulatory obstacles
They offer hope for people who do not respond to conventional treatments or for whom there is no effective therapy yet available: advanced therapy medicinal products (ATMPs). The first of these novel medications, developed using genetic and cell technologies, were officially approved just five years…